New miracle cure for deadly Hepatitis C+#علاج فيروس سى _#Daklinza,#دكلينزا,daklinza_وداعا ل #بيزنس الكبد فى مصر
شوفوا التاريخ لكى ننجو من الخداع
Daclatasvir (Daklinza) for Chronic Hepatitis C Cleared in EU
 | |
| #علاج فيروس سى _#Daklinza,#دكلينزا,daklinza |
- Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza (daclatasvir) and Sunvepra (asunaprevir) Dual Regimen - (Bristol-Myers Squibb)
- Bristol-Myers: Japan Approves Hepatitis C Treatment With Daklinza And Sunvepra - (NASDAQ)
- Japan Approves Bristol-Myers Squibb's Hepatitis C Treatment - (The Wall Street Journal)
- Bristol-Myers hepatitis C drug gets approval in Japan - (Yahoo!Finance)
- Bristol-Myers Squibb Treatment for Hepatitis C Approved - (Zolmax News)
- وكمان عشان الدكترة والصيدلانية
- Bristol-Myers Squibb's all-oral regimen gains FDA breakthrough therapy status for hepatitis C
- Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple Investigational All-oral Combinations across Hepatitis C Genotypes at The International Liver Congress
- All-Oral Treatment Regimen of Bristol-Myers Squibb’s Investigational NS5A and NS3 Inhibitors Achieved 90% Sustained Virologic Response (SVR12) in Phase II Study Sentinel Cohort of Genotype 1b Null Responders
- Bristol-Myers Squibb's Daklinza gains positive CHMP opinion for hepatitis C
- Bristol-Myers Squibb's hepatitis C therapy Daklinza gains EU approval for combination use
تعليقات
إرسال تعليق